Latest filing published 13 Oct 2016 for FIVE PRIME THERAPEUTICS INC, €1,362.
Insider track record
No signal scores available.
R. Lee Douglas: trading record in brief
R. Lee Douglas discloses dealings in Five Prime Therapeutics Inc to SEC (Form 4). In total, 3 filings cover trades dated from 23 September 2013 to 12 October 2016.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 13 October 2016: an option exercise of €1,362, in Five Prime Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to R. Lee Douglas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,219.5 shares@ US$1.23100.0% of flowCommon StockSEC:0001209191-16-145764:0
- 4,065 sharesCommom StockSEC:0001123292-13-001404:0
- 119 sharesCommom StockSEC:0001123292-13-001404:1
3 of 3 declarations
